Apr 14, 2021, 12:55 PM
(From The Washington Post) Several universities halted vaccine distribution efforts Tuesday after federal health officials announced they would review “extremely rare” cases of potentially dangerous blood clots in recipients of the Johnson & Johnson vaccine. In some cases, like at the University of Virginia, officials said they will lean on existing supplies of the Pfizer-BioNTech and Moderna vaccines. Many campuses counted on the one-dose vaccine to inoculate students before summer — which begins at some schools in early May.
Listen to the latest episode of the Net Assets podcast.
